Decursin, an Active Compound Isolated from Angelica gigas, Inhibits Fat Accumulation, Reduces Adipocytokine Secretion and Improves Glucose Tolerance in Mice Fed a High‐Fat Diet
Authors:
- 4 October 2011
- journal article
- research article
- Published by Wiley in Phytotherapy Research
- Vol. 26 (5) , 633-638
Abstract
Decursin (De), an active component of Angelica gigas, is known to exert anticancer and neuroprotective effects. However, its antiobesity and antidiabetic potential has not yet been investigated. This study evaluated the antiobesity effect of decursin, particularly focusing on its ability to inhibit adipocyte differentiation in 3 T3‐L1 cells. Decursin treatment resulted in the inhibition of adipocyte differentiation and the expression of fatty acid synthase. The study further investigated these antiobesity effects using mice fed a normal diet (ND), a high‐fat diet (HFD) and a HFD plus decursin 200 mg/kg diet (HFD + De) for 7 weeks. Mice administered HFD plus decursin showed a drastic decrease in weight gain, triglyceride content, total cholesterol content and fat size compared with those that received the HFD alone; this was observed despite similar quantities of total food intake. Furthermore, decursin improved glucose tolerance in mice fed a HFD. Finally, administration of decursin along with the HFD significantly reduced the secretion of HFD‐induced adipocytokines such as leptin, resistin, IL‐6 and MCP‐1. These results suggest that decursin might be useful for the treatment of obesity and diabetes. Copyright © 2011 John Wiley & Sons, Ltd.Keywords
This publication has 26 references indexed in Scilit:
- Is leptin involved in phagocytic NADPH oxidase overactivity in obesity? Potential clinical implicationsJournal Of Hypertension, 2010
- Hexosamine flux, the O-GlcNAc modification, and the development of insulin resistance in adipocytesMolecular and Cellular Endocrinology, 2010
- Role of Heme Oxygenase in Inflammation, Insulin-Signalling, Diabetes and ObesityMediators of Inflammation, 2010
- Decursin and decursinol inhibit VEGF-induced angiogenesis by blocking the activation of extracellular signal-regulated kinase and c-Jun N-terminal kinaseCancer Letters, 2009
- Adipocytokines and liver diseaseJournal of Gastroenterology, 2008
- Inflammatory Responses Underlying the Microvascular Dysfunction Associated with Obesity and Insulin ResistanceMicrocirculation, 2007
- Obesity, Insulin Resistance, and Renal FunctionMicrocirculation, 2007
- Decursinol and decursin protect primary cultured rat cortical cells from glutamate-induced neurotoxicityJournal of Pharmacy and Pharmacology, 2007
- Decursin Inhibits Induction of Inflammatory Mediators by Blocking Nuclear Factor-κB Activation in MacrophagesMolecular Pharmacology, 2006
- Exercise and obesityCoronary Artery Disease, 2000